11/19/2024
8:48 PM | Kelly Timothy Edwin (Reporting)
Praxis Precision Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
8:50 PM | Mastrocola Lauren (Reporting)
Praxis Precision Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2024
8:30 PM | Mastrocola Lauren (Reporting)
Praxis Precision Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2024
8:30 PM | Nemiroff Alex (Reporting)
Praxis Precision Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
6:53 PM | Point72 Asset Management, L.P. (Filed by)
Praxis Precision Medicines (Subject)
| Form SC 13G/A | |
11/14/2024
4:50 PM | Praxis Precision Medicines (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024
4:46 PM | Praxis Precision Medicines (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G/A | |
|
11/14/2024
2:08 PM | Cormorant Asset Management, LP (Filed by)
Praxis Precision Medicines (Subject)
| Form SC 13G/A | |
11/14/2024
1:32 PM | Mastrocola Lauren (Reporting)
Praxis Precision Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024
12:45 PM | Nemiroff Alex (Reporting)
Praxis Precision Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024
8:23 AM | Praxis Precision Medicines (Subject)
Verition Fund Management LLC (Filed by)
| Form SC 13G/A | |
11/12/2024
12:29 PM | Capital Research Global Investors (Filed by)
Praxis Precision Medicines (Subject)
| Form SC 13G | |
11/12/2024
8:35 AM | Adage Capital Management, L.P. (Filed by)
Praxis Precision Medicines (Subject)
| Form SC 13G/A | |
11/06/2024
6:59 AM | Praxis Precision Medicines (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2024
6:57 AM | Praxis Precision Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/22/2024
2:24 PM | BlackRock, Inc. (Filed by)
Praxis Precision Medicines (Subject)
| Form SC 13G | |
10/15/2024
7:00 AM | Praxis Precision Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/23/2024
4:42 PM | PERCEPTIVE ADVISORS LLC (Filed by)
Praxis Precision Medicines (Subject)
| Form SC 13G | |
09/03/2024
7:15 AM | Praxis Precision Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
6:20 AM | Praxis Precision Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
6:22 AM | Praxis Precision Medicines (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/31/2024
8:00 PM | Kelly Timothy Edwin (Reporting)
Praxis Precision Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2024
8:01 PM | Mastrocola Lauren (Reporting)
Praxis Precision Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2024
8:02 PM | Nemiroff Alex (Reporting)
Praxis Precision Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2024
8:03 PM | Praxis Precision Medicines (Issuer)
Souza Marcio (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2024
8:31 PM | Praxis Precision Medicines (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G | |
06/06/2024
5:55 PM | Norden Gregory (Reporting)
Praxis Precision Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
5:55 PM | Praxis Precision Medicines (Issuer)
YOUNG WILLIAM D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
5:55 PM | Cudkowicz Merit Ester (Reporting)
Praxis Precision Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
5:56 PM | Chodakewitz Jeffrey (Reporting)
Praxis Precision Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
5:56 PM | MITCHELL DEAN J (Reporting)
Praxis Precision Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
5:56 PM | DeSimone Jill (Reporting)
Praxis Precision Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
4:09 PM | Praxis Precision Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/20/2024
7:10 AM | Praxis Precision Medicines (Issuer)
Souza Marcio (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
7:10 AM | Kelly Timothy Edwin (Reporting)
Praxis Precision Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2024
7:18 AM | Praxis Precision Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
7:21 AM | Praxis Precision Medicines (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/26/2024
6:46 AM | Praxis Precision Medicines (Filer)
| Form DEF 14A | |
04/26/2024
6:47 AM | Praxis Precision Medicines (Filer)
| Form DEFA14A | |
03/29/2024
3:29 PM | Praxis Precision Medicines (Filer)
| Form 424B5 | |
03/29/2024
3:30 PM | Praxis Precision Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
2025 AI Stock Picks: 2 Hidden Gems Under $10/Share (Ad) The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget!
We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months. 👉[Click here to get your FREE report delivered instantly!] |
03/27/2024
3:49 PM | Praxis Precision Medicines (Filer)
| Form 424B5 | |
03/26/2024
6:01 AM | Praxis Precision Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/12/2024
11:15 PM | Praxis Precision Medicines (Filer)
| Form EFFECT | |
03/05/2024
8:08 AM | Praxis Precision Medicines (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/05/2024
6:33 AM | Praxis Precision Medicines (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/05/2024
6:12 AM | Praxis Precision Medicines (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/05/2024
6:13 AM | Praxis Precision Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
7:45 PM | Praxis Precision Medicines (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G/A | |
02/14/2024
11:21 AM | EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Praxis Precision Medicines (Subject)
| Form SC 13G/A | |
02/14/2024
7:55 AM | Praxis Precision Medicines (Subject)
Verition Fund Management LLC (Filed by)
| Form SC 13G | |
02/13/2024
6:08 PM | Avidity Partners Management LP (Filed by)
Praxis Precision Medicines (Subject)
| Form SC 13G/A | |
02/09/2024
4:21 PM | Blackstone Holdings I/II GP L.L.C. (Filed by)
Praxis Precision Medicines (Subject)
| Form SC 13G/A | |
02/07/2024
6:46 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Praxis Precision Medicines (Subject)
| Form SC 13G/A | |
02/06/2024
4:10 PM | KINGDON CAPITAL MANAGEMENT, L.L.C. (Filed by)
Praxis Precision Medicines (Subject)
| Form SC 13G/A | |
02/05/2024
8:13 AM | Praxis Precision Medicines (Subject)
SPHERA FUNDS MANAGEMENT LTD. (Filed by)
| Form SC 13G/A | |
01/17/2024
3:47 PM | Mastrocola Lauren (Reporting)
Praxis Precision Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
3:48 PM | Nemiroff Alex (Reporting)
Praxis Precision Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
3:49 PM | Praxis Precision Medicines (Issuer)
Souza Marcio (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
3:51 PM | Kelly Timothy Edwin (Reporting)
Praxis Precision Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/12/2024
4:20 PM | Praxis Precision Medicines (Filer)
| Form 424B5 | |
01/12/2024
4:23 PM | Praxis Precision Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/11/2024
5:01 AM | Praxis Precision Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2024
4:28 PM | Praxis Precision Medicines (Filer)
| Form 424B5 | |
01/10/2024
3:10 PM | Praxis Precision Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/09/2024
8:08 PM | Mastrocola Lauren (Reporting)
Praxis Precision Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
8:09 PM | Praxis Precision Medicines (Issuer)
Souza Marcio (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
8:10 PM | Nemiroff Alex (Reporting)
Praxis Precision Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
8:11 PM | Kelly Timothy Edwin (Reporting)
Praxis Precision Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2023
4:19 PM | Praxis Precision Medicines (Filer)
| Form 424B5 | |
12/07/2023
4:23 PM | Praxis Precision Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/01/2023
3:33 PM | Praxis Precision Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/22/2023
3:30 PM | Praxis Precision Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
